Literature DB >> 28317625

Relationship Among Pulmonary Hypertension, Autoimmunity, Thyroid Hormones and Dyspnea in Patients With Hyperthyroidism.

Sayid Shafi Zuhur1, Derya Baykiz2, Sonat Pinar Kara3, Ertan Sahin4, Idris Kuzu5, Gulsah Elbuken6.   

Abstract

OBJECTIVE: Previous studies have reported conflicting results regarding the mechanisms underlying the pathophysiology of pulmonary hypertension (PHT) in patients with hyperthyroidism. Therefore, in this study, we investigated the association between PHT and thyroid-stimulating hormone (TSH) receptor antibody, thyroid peroxidase antibody, thyroglobulin antibody, TSH, fT3, fT4 and dyspnea during daily activities in a large population of patients with hyperthyroidism.
METHODS: A total of 129 consecutive patients with hyperthyroidism, 37 with hypothyroidism and 38 euthyroid controls were enrolled in this study. The modified medical research council scale was used for the assessment of dyspnea in daily activities. All the patients and euthyroid controls underwent transthoracic echocardiography for the assessment of PHT.
RESULTS: Mild PHT was present in 35%, 36%, 13.5% and 5% of the patients with Graves׳ disease, toxic multinodular goiter, hypothyroidism and euthyroid controls, respectively. Pulmonary vascular resistance (PVR) was higher in hyperthyroid patients with PHT than in those without PHT. Moreover, a significant positive correlation was found between modified medical research council scale and pulmonary artery systolic pressure as well as PVR in patients with hyperthyroidism. No association was found between PHT and serum TSH receptor antibody, thyroid peroxidase antibody, thyroglobulin antibody, TSH, fT3 and fT4 levels.
CONCLUSIONS: Mild PHT is present in a significant proportion of patients with hyperthyroidism, regardless of etiology. PVR appears to be the main cause of PHT in patients with hyperthyroidism, and neither autoimmunity nor thyroid hormones are associated with PHT in these patients. Mild dyspnea during daily activities in patients with hyperthyroidism may be related to PHT; however, severe dyspnea requires further evaluation.
Copyright © 2017 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoimmunity; Hyperthyroidism; Hypothyroidism; Pulmonary hypertension; TRAb

Mesh:

Substances:

Year:  2017        PMID: 28317625     DOI: 10.1016/j.amjms.2017.01.016

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  5 in total

1.  The clinical characteristics and outcomes of patients with pulmonary hypertension in association with hyperthyroid state: A systematic review.

Authors:  Fateen Ata; Adeel Ahmad Khan; Zohaib Yousaf; Hassan Choudry; Areej Marwan Mohammed; Bilal Ahmed; Ahmed Muaaz Umer; Fareeha Khan; Dabia Hamad Sh Al Mohanadi; Emad Naem; Muhammad Zahid
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

2.  Right ventricular dysfunction and pulmonary hypertension: a neglected presentation of thyrotoxicosis.

Authors:  Carolina Shalini Singarayar; Foo Siew Hui; Nicholas Cheong; Goay Swee En
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2018-05-16

3.  Echocardiographic evolution of pulmonary hypertension in female patients with hyperthyroidism.

Authors:  Cristina Tudoran; Mariana Tudoran; Mihaela Vlad; Melania Balas; Gheorghe Nicusor Pop; Florina Parv
Journal:  Anatol J Cardiol       Date:  2018-09       Impact factor: 1.596

4.  Impact of Hypothyroidism on Echocardiographic Characteristics of Patients With Heart Valve Disease: A Single-Center Propensity Score-Based Study.

Authors:  Tianyu Zhai; Zhenqin Cai; Jiayu Zheng; Yan Ling
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-24       Impact factor: 5.555

5.  Interplay Between Thyroid Hormone Status and Pulmonary Hypertension in Graves' Disease: Relevance of the Assessment in Thyrotoxic and Euthyroid Patients.

Authors:  Larisse Vieira Mendes Araruna; Daniela Camargo de Oliveira; Mônica Corso Pereira; Arnaldo Moura Neto; Marcos Antonio Tambascia; Denise Engelbrecht Zantut-Wittmann
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-06       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.